Bellevue Life Sciences AcquiBLACU
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$10.86avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Bellevue Life Sciences Acqui (BLACU) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Clear Street LLC ($40K) and Tower Research Capital LLC (TRC) ($109).
- Company
- Bellevue Life Sciences Acqui
- CUSIP
- 079174207
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 48 shares sold, net −48 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Clear Street LLC | 0.00% | Reduce -1.3% | 3,712 | $40K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 10 | $109 |
"% of holder's portfolio" is BLACU's weight in each manager's 13F, not the share of Bellevue Life Sciences Acqui the manager owns.